Elicio Therapeutics, Inc. — Form D
Elicio Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-29. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-03-29
- Form: D
- Accession: 0001601485-24-000017
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 1
- Date of first sale: 2024-03-19
- Revenue range: Decline to Disclose
- SEC file number: 021-509031
Issuer
- Name: Elicio Therapeutics, Inc.
- CIK: 0001601485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 451 D Street, Boston, MA, 02210
- Phone: (857) 209-0050
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Julian Adams | Director | Boston, MA |
| Carol Ashe | Director | Boston, MA |
| Yekaterina Chudnovsky | Director | LOS ANGELES, CA |
| Robert Connelly | Director | Boston, MA |
| Allen Nissenson | Director | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Jay Venkatesan | Director | Boston, MA |
| Karen Wilson | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Peter DeMuth | Executive Officer | Boston, MA |
| Christopher Haqq | Executive Officer | Boston, MA |
| Brian Piekos | Executive Officer | Boston, MA |
| Allen R Nissenson | Director | San Francisco, CA |
| Jay R Venkatesan | Director | San Francisco, CA |
| Jay R Venkatesan | Executive Officer | San Francisco, CA |
| Karen R Wilson | Director | San Francisco, CA |
| Itzhak D Goldberg | Director | Uniondale, NY |
| Itzhak D Goldberg | Executive Officer | Uniondale, NY |
| Victor R Ganzi | Director | San Francisco, CA |
| Gil R Omenn | Director | San Francisco, CA |
| Michael R Yamin | Director | Uniondale, NY |
| Jay D Venkatesan | Director | Uniondale, NY |
| Jay D Venkatesan | Executive Officer | Uniondale, NY |
| Michael D Yamin | Director | Uniondale, NY |
Other filings by this issuer (7)
More